MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

P. de la Puente; B. Muz; A. Jin; F. Azab; M. Luderer; N. N. Salama; A. K. Azab

doi:10.1038/BCJ.2016.7

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

P. de la Puente, B. Muz, A. Jin, F. Azab, M. Luderer, N. N. Salama, A. K. Azab

Pharmaceutical and Administrative Sciences Department

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e399
Journal	Blood Cancer Journal
Volume	6
Issue number	2
DOIs	https://doi.org/10.1038/BCJ.2016.7
State	Published - 2016

ASJC Scopus Subject Areas

Hematology
Oncology

Access to Document

10.1038/BCJ.2016.7

Cite this

@article{8ea822cbfe9b45c988e472efe4db227c,

title = "MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma",

author = "{de la Puente}, P. and B. Muz and A. Jin and F. Azab and M. Luderer and Salama, {N. N.} and Azab, {A. K.}",

year = "2016",

doi = "10.1038/BCJ.2016.7",

language = "English",

volume = "6",

journal = "Blood Cancer Journal",

issn = "2044-5385",

number = "2",

}

TY - JOUR

T1 - MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

AU - de la Puente, P.

AU - Muz, B.

AU - Jin, A.

AU - Azab, F.

AU - Luderer, M.

AU - Salama, N. N.

AU - Azab, A. K.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84995423367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995423367&partnerID=8YFLogxK

U2 - 10.1038/BCJ.2016.7

DO - 10.1038/BCJ.2016.7

M3 - Letter

C2 - 26918363

AN - SCOPUS:84995423367

SN - 2044-5385

VL - 6

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 2

M1 - e399

ER -

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this